X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/delsitech-and-tolmar-announce-global-license-and-development-agreement-302059757.html
https://www.prnewswire.com/news-releases/delsitech-announces-closing-of-eur-10-million-financing-round-to-advance-its-silica-based-drug-delivery-technology-platform-302034841.html
https://www.prnewswire.com/news-releases/delsitech-announces-positive-topline-clinical-data-from-phase-1-trial-with-its-sustained-release-eye-drop-platform-301866331.html
https://www.prnewswire.com/news-releases/delsitech-awarded-a-grant-to-develop-controlled-and-sustained-release-injectables-for-prophylactic-hiv-vaccine-301772580.html
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/biopharma-news/exclusive-agreement-permits-commercialisation-of-amd-treatme/
https://www.fiercepharma.com/pharma/zimura-20-iveric-taps-delsitech-develop-sustained-release-form-retinal-disease-prospect
https://www.fiercepharma.com/pharma/seeking-shake-eye-inflammation-market-optifye-and-delsitech-partner-controlled-release-drops
https://www.prnewswire.com/news-releases/delsitech-enters-into-an-exclusive-licensing-agreement-with-optifye-therapeutics-for-the-development-of-a-controlled-release-ophthalmic-eye-drop-product-301510917.html
Market Place
Share 
